tobiegi's profile picture. Corporate Affairs Leader | Change Champion | DEI Advocate | 🇪🇺

Thomas Biegi

@tobiegi

Corporate Affairs Leader | Change Champion | DEI Advocate | 🇪🇺

You might like
Thomas Biegi reposted

Thanks ⁦@MikeHuckman⁩ ⁦@RealChemistry_⁩ for leading the spin class at #JPM23. All proceeds go to Kilimanjaro Climb to Fight Cancer ⁦@fredhutch

ldtimmerman's tweet image. Thanks ⁦@MikeHuckman⁩ ⁦@RealChemistry_⁩ for leading the spin class at #JPM23. All proceeds go to Kilimanjaro Climb to Fight Cancer ⁦@fredhutch⁩

This #BloodCancerAwarenessMonth, my colleagues and I committed to doing “more.” More education. More discoveries. More collaboration. More inspiration. Read below to hear from our CEO, Jean-Paul Kress, and learn about his commitments for the future.

This post is unavailable.

I am so proud that we are flying the rainbow flag in front of our office for the first time to express our commitment for #diversity and #inclusion every day. It's so important that colleagues know they can bring their full selves to work, no matter how they identify. #PrideMonth

This post is unavailable.

One in five Gen Z adults identifies as LGBTQ, Gallup finds axios.com/lgbtq-generati…


I am so proud about our team and the high level of commitment we share to bring breakthrough medicines to people with #cancer and closing the care gap. Take a look! #WorldCancerDay #CloseTheCareGap

This post is unavailable.

Thomas Biegi reposted

Der Finanzvorstand von #Morphosys, Sung Lee, erläutert die hohen Ziele des #Biotechnologieunternehmens und erklärt den steilen Kursrutsch nach dem Zukauf von #Constellation in den USA. @MorphoSys boersen-zeitung.de/unternehmen-br…


It’s amazing to be back in Boston on #WorldLymphomaAwarenessDay and seeing the @MorphoSys office glowing in red to honor Blood Cancer Awareness Month in September #BCAM2021

tobiegi's tweet image. It’s amazing to be back in Boston on #WorldLymphomaAwarenessDay and seeing the @MorphoSys office glowing in red to honor Blood Cancer Awareness Month in September #BCAM2021

Thomas Biegi reposted

When MorphoSys AG (Nasdaq: MOR) acquired oncology firm Constellation Pharmaceuticals Inc. for $1.7 billion, it instantly doubled its Boston-area headcount — and according to CEO Jean-Paul Kress, the company has no plans to slow down local growth. bizjournals.com/boston/news/20…


Exciting day in the office today, celebrating Day 1 for MorphoSys and Constellation!

This post is unavailable.

Thomas Biegi reposted

MorphoSys, After Its Commercial Debut, Looks To The Next Growth Phase bit.ly/3s3S6qw #PharmaScrip


Bravo! It’s so important to have visible role models in all aspects of life #actout

Das große Interview zu #actout finden Sie am heutigen Freitag im Heft in der @SZ und mit SZ Plus unter sz-magazin.de/actout



Thomas Biegi reposted

NEWS: The Pfizer-@BioNTech_Group #COVID19 vaccine has not been approved or licensed by the @US_FDA but has been authorized for emergency use to prevent COVID-19 in individuals 16 & older. See conditions of use: cvdvaccine.com


A new adventure begins… I’m honored to join @MorphoSys as head of corporate communciations. I can't wait to talk more about the great work the team is doing on their journey to become a full-blown biopharma company.

Das große Interview zu #actout finden Sie am heutigen Freitag im Heft in der @SZ und mit SZ Plus unter sz-magazin.de/actout



The Husband-and-Wife Team Behind the Leading Vaccine to Solve Covid-19 nytimes.com/2020/11/10/bus…


WAKE UP! IT’S A BEAUTIFUL MONDAY MORNING. WE HAVE POSITIVE #COVID19 VACCINE DATA FROM PFIZER AND BIONTECH!



It’s a good day

Joe Biden has been elected the next president of the United States. nyti.ms/357eQxu

nytimes's tweet image. Joe Biden has been elected the next president of the United States. nyti.ms/357eQxu


Thomas Biegi reposted

Transparency is important so I’d like to provide greater clarity around the timelines for @pfizer’s #COVID19 vaccine and the 3 key areas where we must demonstrate success in order to submit for Emergency Use Authorization (EUA) or Approval: on.pfizer.com/2ICBOUv


United States Trends

Loading...

Something went wrong.


Something went wrong.